EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lobaric Acid Exhibits Anticancer Potential by Modulating the Wnt/β‐Catenin Signaling Pathway in MCF‐7 Cells

Şeyda Nur Kalın, Kübra Nur Bayındırlı, Emine Toraman, Şükran Günaydın, Fatmanur Keleş, Ahmet Altay, Harun Budak iD

Pharmacology Research & Perspectives · 2025

DOI: 10.1002/prp2.70142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Şeyda Nur Kalın und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Science Faculty, Atatürk University, Erzurum, Turkey. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Antineoplastic Agents, Breast Neoplasms. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lichen secondary metabolites with many remarkable biological activities are used in cancer treatments due to their low side effects and high anticancer potential. In particular, these metabolites constitute an interesting research area in cancer treatments due to their potential to induce apoptosis and suppress metastasis by inhibiting cancer‐related signaling pathways. The Wnt/β‐catenin signaling pathway plays a role in important biological processes such as oncogenesis, cell cycle regulation, cell proliferation, metastasis, differentiation, apoptosis, and drug resistance. Therefore, inhibition of this pathway is a potential target in cancer therapies. There is no detailed study explaining the potential anticancer molecular mechanism of the lichen secondary metabolite lobaric acid (LA) on breast cancer. Here, it is aimed to investigate the effect of LA on viability, apoptosis, and migration in MCF‐7 cells and to elucidate the relationship between the potential anticancer effect and the Wnt/β‐catenin signaling pathway. The dose‐ and time‐dependent viability of LA‐treated MCF‐7 cells was evaluated by XTT assay, and the IC 50 value was determined as 44.21 μg/mL at 48 h. LA increased the apoptotic cell population, as shown by flow cytometry analysis, qPCR, and Western blot results. LA inhibited β‐catenin by inducing GSK3‐β protein expression, thereby suppressing Wnt/β‐catenin target genes. LA might be a natural active compound candidate for breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wnt Signaling PathwayAntineoplastic AgentsBreast NeoplasmsHumansMCF-7 CellsApoptosisCell SurvivalCell MovementLichensFemalebeta CateninCell ProliferationGlycogen Synthase Kinase 3 beta

Stichwörter der Autor:innen

Wnt/β‐catenin pathwayapoptosisbreast cancercytotoxicityexpression

Substanzen

Antineoplastic Agentsbeta CateninGlycogen Synthase Kinase 3 beta

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Science Faculty, Atatürk University, Erzurum, Turkey.
  • Department of Chemistry, Faculty of Science and Arts, Erzincan Binali Yıldırım University, Erzincan, Turkey.
  • Department of Laboratory and Veterinary Sciences, Narman Vocational College, Atatürk University, Erzurum, Turkey.
  • Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Kütahya Health Sciences University, Kütahya, Turkey.

ORCID-Profile: Harun Budak

Zitieren

APA

Kalın, Ş. N., Bayındırlı, K. N., Toraman, E., Günaydın, Ş., Keleş, F., Altay, A., & Budak, H. (2025). Lobaric Acid Exhibits Anticancer Potential by Modulating the Wnt/β‐Catenin Signaling Pathway in MCF‐7 Cells. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70142

Vancouver

Kalın ŞN, Bayındırlı KN, Toraman E, Günaydın Ş, Keleş F, Altay A, et al. Lobaric Acid Exhibits Anticancer Potential by Modulating the Wnt/β‐Catenin Signaling Pathway in MCF‐7 Cells. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70142

BibTeX
@article{Kaln2025,
  author = {Kalın, Şeyda Nur and Bayındırlı, Kübra Nur and Toraman, Emine and Günaydın, Şükran and Keleş, Fatmanur and Altay, Ahmet and Budak, Harun},
  title = {Lobaric Acid Exhibits Anticancer Potential by Modulating the Wnt/β‐Catenin Signaling Pathway in MCF‐7 Cells},
  journal = {Pharmacology Research & Perspectives},
  year = {2025},
  doi = {10.1002/prp2.70142}
}
Kostenlos starten →